Overall, in 2024, more than 3,000 professionals from close to 60 countries were trained in 29 nations on the treatment of drug use disorders, and more than 50,000 people were reached by those trained ...

Trastuzumab deruxtecan approved to treat adults with HER2-positive cancer that’s spread or can’t be removed by surgery.